- Platform Technologies
Bio21's Associate Professor Neil O’Brien-Simpson and Professor Eric Reynolds from the Faculty of Medicine, Dentistry and Health Sciences and Bio21 Institute were on the team that created the star-shaped ‘peptide polymer’ structures that hold promise for a new treatment methods against superbugs.
Bio21 Big Picture Seminar: Alternative Drug Discovery in Pharma...a snapshot of diversity in GSK drug discovery through collaboration
Hear John Haselden, VP and Head of Malaria Discovery GSK speak about examples from GSK’s 'alternative' portfolio, including Diseases of the Developing World and Maternal/Neonatal Health.
This free computer lab tutorial will provide attendee’s the opportunity to try Ingenuity Pathway Analysis (IPA) software.
Congratulations to Bio21's Kat Holt, recipient of the Georgina Sweet Award for Quantitative Biomedical Science.
Bio21's Professor Paul Mulvaney is the new Director of the Centre of Excellence in Exciton Science.